NEW YORK (GenomeWeb) – Swiss diagnostic firm ProteoMedix today announced the second closing of a Series B financing round of CHF1 million ($1.1 million), bringing the total amount raised in the round to CHF4.2 million.

Zurich-based ProteoMedix, which spun out of the lab of Swiss Federal Institute of Technology researcher Ruedi Aebersold in 2010, raised CHF3.2 million in the first round of the Series B financing last April.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.